Trillium Therapeutics (TRIL) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Novartis strengthens radiopharma leadership with Ratio Therapeutics dealNovember 20, 2024 | yahoo.comZentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of AzenosertibNovember 13, 2024 | markets.businessinsider.comTTI, REPX among major energy losers; EU major gainerMay 1, 2024 | msn.comSYRE Spyre Therapeutics, Inc.April 11, 2024 | seekingalpha.comViking Therapeutics Stock (NASDAQ:VKTX), Analyst Ratings, Price Targets, PredictionsFebruary 22, 2024 | benzinga.comBlue Cross & Blue Shield of Rhode Island Insurance Company Medicare Advantage Plans with Part DFebruary 21, 2024 | health.usnews.com2023-2030 Bromodomain Containing Protein 2 Market Size Detailed Report with Sales and Revenue Analysis | Research by Absolute ReportsApril 7, 2023 | marketwatch.comMonte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of DirectorsMarch 23, 2023 | finance.yahoo.comRatio Therapeutics Appoints Dr. Noel Monks as Head of BiologyMarch 13, 2023 | finance.yahoo.comFactbox: Pfizer snaps up Seagen for $43 bln as drugmaker extends buying spreeMarch 13, 2023 | reuters.comAllogene Therapeutics Stock (NASDAQ:ALLO), Quotes and News SummaryFebruary 24, 2023 | benzinga.comTvardi Therapeutics Announces First Patients Dosed in Phase 2 Trial of TTI-101 in Metastatic Breast CancerFebruary 23, 2023 | finance.yahoo.comViridian Therapeutics Names Scott Myers CEO, Succeeding Jonathan ViolinFebruary 6, 2023 | markets.businessinsider.comAlex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxietyOctober 26, 2022 | finance.yahoo.comPfizer in advanced talks to buy Global Blood Therapeutics for $5 billion - WSJAugust 5, 2022 | finance.yahoo.comLeukemia Therapeutics Global Market Report 2022July 29, 2022 | ca.finance.yahoo.comTrillium Therapeutics Inc. NewsJuly 18, 2022 | thestreet.comRatio Therapeutics Launches to Discover and Drive Early Clinical Development of Best-in-Class Targeted Radiopharmaceuticals for Treatment of CancersJune 10, 2022 | finance.yahoo.comPfizer Pays $11.6 Billion for Drug-Maker in Its Biggest Deal Since 2016May 10, 2022 | chron.comBloom Burton & Co. Inc.: Three Finalists Announced for the 2022 Bloom Burton AwardMay 10, 2022 | finanznachrichten.deThree Finalists Announced for the 2022 Bloom Burton AwardMay 10, 2022 | stockhouse.comPfizer to buy migraine drugmaker Biohaven in $11.6-billion dealMay 10, 2022 | yahoo.comGenScript ProBio Initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation BioJanuary 26, 2022 | finance.yahoo.comCD47 Targeting Global Therapeutics Market 2021-2035, by Target Disease Indication, Type of Molecule Key Players and Key Geographical RegionsDecember 16, 2021 | au.finance.yahoo.comTrillium Therapeutics Receives Final Court Order Approving ArrangementOctober 28, 2021 | finance.yahoo.comShareholders of cancer-drug developer Trillium Therapeutics approve takeover by Pfizer Inc.October 26, 2021 | theglobeandmail.comTrillium Securityholders Approve Acquisition by PfizerOctober 26, 2021 | finance.yahoo.comPfizer Gives Gov't More Time To Study $2.3B Trillium DealOctober 13, 2021 | law360.comIs Trillium Therapeutics Inc. (TSE:TRIL) Popular Amongst Institutions?October 5, 2021 | finance.yahoo.comHere's the Biotech Pfizer Should Consider Acquiring NextSeptember 14, 2021 | markets.businessinsider.comINVESTIGATION: Halper Sadeh LLP Investigates LMRK, HFC, NLOK, TRIL, LDL; Shareholders are Encouraged to Contact the FirmAugust 26, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. (Nasdaq – TRIL)August 24, 2021 | finance.yahoo.comTRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium ...August 23, 2021 | businesswire.comTrillium, Analog Devices rise: General Motors, Lennar fallStocks that traded heavily or had substantial price changes Monday: Trillium, Analog Devices rise; General Motors, Lennar fallAugust 23, 2021 | marketbeat.comTop 5 Stock Gainers for Monday: Pfizer, Trillium, NextGen, VivosAugust 23, 2021 | thestreet.comMid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium TherapeuticsAugust 23, 2021 | markets.businessinsider.comPfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See HighlightsAugust 23, 2021 | finance.yahoo.comWhy Trillium Therapeutics Stock Is Skyrocketing TodayAugust 23, 2021 | finance.yahoo.comPfizer to Acquire Cancer Drugmaker Trillium for $2.3 BillionAugust 23, 2021 | finance.yahoo.comPfizer Agrees to Buy Cancer Biotech Trillium Therapeutics at a 200% PremiumAugust 23, 2021 | finance.yahoo.comPfizer Nabs Cancer Deal For $2.26 Billion, Helping Trillium Stock SkyrocketAugust 23, 2021 | finance.yahoo.comTropical Storm Henri’s mayhem, Boeing invests in Virgin Orbit, Pfizer’s newest acquisitionAugust 23, 2021 | finance.yahoo.comTrillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TRILAugust 23, 2021 | finance.yahoo.comPfizer to pay $2.26B for cancer treatment developer TrilliumPfizer is spending more than $2 billion in cash to buy another drugmaker focused on potential cancer treatmentsAugust 23, 2021 | marketbeat.comTrillium: Q2 Earnings SnapshotAugust 13, 2021 | chron.comNorth American Morning Briefing: Investors Await -3-August 11, 2021 | morningstar.comTSX falls 0.06% to 20,097.52July 22, 2021 | finance.yahoo.com Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIL Media Mentions By Week TRIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRIL News Sentiment▼0.000.43▲Average Medical News Sentiment TRIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRIL Articles This Week▼00▲TRIL Articles Average Week Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aptose Biosciences News Fennec Pharmaceuticals News Medicenna Therapeutics News Oncolytics Biotech News Covalon Technologies News Theratechnologies News Sernova News Microbix Biosystems News Devonian Health Group News Hemostemix News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:TRIL) was last updated on 3/7/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trillium Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trillium Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
